Is your pharma brand AI-ready? The future of HCP and patient engagement in an LLM-first world

The future of HCP and patient engagement in an LLM-first world

Findings from a study of 500 US clinicians comparing how their use of GenAI is changing.
A demo of Open Evidence, the tool that provides clinicians with traceable, verifiable references.
Chema Guido Avila (Sanofi) on why pharma needs to rethink its brand mindset when the audience is increasingly an LLM, not a person.
How pharma can support clinicians through the AI journey, as 6 in 10 say they need to retrain themselves.

Guests

Dr Michael Housman

Founder & CEO, AI-ccelerator

Reena Sooch

Partner, Digital & AI, Day One Strategy

Jose Maria (Chema) Guido Avila

Global Patient Experience Lead, Sanofi

Next webinar

Who can you trust? A pharma leader’s guide to vetting AI for insights